D
DRRX
DURECT
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Reuters·10/29/2025 20:45
Bausch Health Q3 revenue rises, partly driven by DURECT acquisition
Reuters·10/29/2025 20:11
Bausch Health Reports Q3 Revenue of $2.68 Billion, Up 7%
NASDAQ·09/11/2025 21:56
Bausch Health Completes $63 Mln Acquisition Of DURECT, Adds Breakthrough AH Therapy
Dow Jones·09/11/2025 21:08
*News On Durect Corp. (DRRX) Now Under BHC.T
TipRanks·09/11/2025 14:48
Durect Merges with Bausch Health, Delists from Nasdaq
Reuters·09/11/2025 14:19
Durect Corporation Announces Delisting from Nasdaq Following Merger Completion
Reuters·09/11/2025 13:52
Bausch Health Completes Acquisition of DURECT Corporation, Solidifying Merger Terms
TipRanks·09/10/2025 13:40
Unusually active option classes on open September 10th
TipRanks·08/26/2025 12:25
Bausch Health announces extension of Durect tender offer
TipRanks·08/23/2025 02:07
Major Investment Alert: Insider Buys Big in Durect!
Reuters·08/22/2025 10:12
Scott Asen, Trustee, Reports Acquisition of Durect Corporation Common Shares
Reuters·08/14/2025 17:50
Durect Corporation Files Initial Statement of Beneficial Ownership for R. Scott Asen
TipRanks·08/13/2025 04:06
DURECT Corporation Reports Q2 2025 Results Amid Acquisition
NASDAQ·08/12/2025 22:05
Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates
Reuters·08/12/2025 20:58
DURECT Corp reports results for the quarter ended June 30 - Earnings Summary
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.